:::

詳目顯示

回上一頁
題名:Treatment-resistant Depression
書刊名:Taiwanese Journal of Psychiatry
作者:Dunner, David L.
出版日期:2013
卷期:27:2
頁次:頁110-120+a6
主題關鍵詞:難治型憂鬱症更換抗憂鬱劑加強抗憂鬱療法Treatment-resistanceSwitching of antidepressantAugmentation of antidepressant therapySTAR*D
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(2) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:2
  • 共同引用共同引用:0
  • 點閱點閱:64
期刊論文
1.Dunner, D. L.(2005)。Treatment-resistant depression: an overview of the problem。Prim Psychiatry,12,8-11。  new window
2.Rush, A. J.、Fava, M.、Wisniewski, S. R.(2004)。Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design。Control Clin Trials,1,119-142。  new window
3.Thase, M. E.、Rush, A. J.(1997)。When at first you don'€™t succeed: sequential strategies for anti-depressant nonresponders。J Clin Psychiatry,58(Suppl 13),23-29。  new window
4.Dunner, D. L.、Rush, A. J.、Russell, J. M.、Woodward, S.、Wingard, P.、Allen, J.(2006)。Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression。J Clin Psychiatry,67,688-695。  new window
5.Csernansky, J. G.、Hollister, L. E.(1986)。Medical management of refractory endogenous depressions。Hospital Formulary,21,206-212。  new window
6.Nelsen, M. R.、Dunner, D. L.(1995)。Clinical and differential diagnostic aspects of treatment resistant depression。J Psychiatr Res,29,43-50。  new window
7.Rush, A. J.、Thase, M. E.(1997)。Strategies and tactics in the treatment of chronic depression。J Clin Psychiatry,58(Suppl 13),14-22。  new window
8.Rush, A. J.、Trivedi, M. H.、Ibrahim, H. M.(2003)。The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician ratings (QIDS-C) and self report (QIDS-SR): a psychometric evaluation in patients with chronic major depression。Biol Psychiatry,54,573-583。  new window
9.Sackeim, H. A.(2001)。The definition and meaning of treatment resistant depression。J Clin Psychiatry,62(Suppl 16),10-17。  new window
10.Price, L. H.、Charney, D. S.、Heninger, G. R.(1986)。Variability of response to lithium augmentation in refractory depression。Am J Psychiatry,143,1387-1392。  new window
11.Joffe, R. T.、Levitt, A. J.、Bagby, R. M.、MacDonald, C.、Singer, W.(1993)。Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders。Br J Psychiatry,163,574-578。  new window
12.Papakostas, G. I.、Clain, A.、Ameral, V. E.(2010)。Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study。Int Clin Psychopharmacol,25,17-21。  new window
13.Thase, M. E.、Howland, R. H.、Friedman, E. S.(1998)。Treating antidepressant nonresponders with augmentation strategies: an overview。J Clin Psychiatry,59(Suppl 5),5-12。  new window
14.Onder, E.、Tural, U.(2003)。Faster response in depressive patients treated with fl uoxetine alone than in combination with buspirone。J Affect Disord,76,223-227。  new window
15.Barbee, J. G.、Thompson, T. R.、Jamhour, N. J.(2011)。A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment- refractory unipolar depression。J Clin Psychiatry,72,1405-1412。  new window
16.Artigas, R.、Perez, V.、Alvarez, E.(1994)。Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors。Arch Gen Psychiatry,51,248-251。  new window
17.Moreno, F. A.、Gelenberg, A. J.、Bachar, K.、Delgado, P. L.(1997)。Pindolol augmentation of treatment-resistant depressed patients。J Clin Psychiatry,58,437-439。  new window
18.Kilbourne, E. M.、Swygert, L. A.、Philen, R. M.(1990)。Interim guidance on the eosinophilia-myalgia syndrome。Ann Intern Med,112,85-87。  new window
19.Papakostas, G. I.、Shelton, R. C.、Zajecka, J. M.(2012)。L-methylfolate as adjunctive therapy for SSRIresistant major depression: results of two randomized, double-blind, parallel-sequential trials。Am J Psychiatry,169,1267-1274。  new window
20.Michelson, D.、Adler, L. A.、Amsterdam, J. D.(2007)。Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study。J Clin Psychiatry,68,582-587。  new window
21.Ostroff, R. B.、Nelson, J. C.(1999)。Risperidone augmentation of selective serotonin reuptake inhibitors in major depression。J Clin Psychiatry,60,256-259。  new window
22.Dunner, D. L.、Amsterdam, J. D.、Shelton, R. C.、Loebel, A.、Romano, S. J.(2007)。Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label study。J Clin Psychiatry,68,1071-1077。  new window
23.Berman, R. M.、Marcus, R. N.、Swanink, R.(2007)。The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo controlled study。J Clin Psychiatry,68,843-853。  new window
24.Berman, R. M.、Fava, M.、Thase, M. E.(2009)。Aripiprazole augmentation in major depressive disorder: a doubleblind, placebo-controlled study in patients with inadequate response to antidepressants。CNS Spectr,14,197-206。  new window
25.Bauer, M.、Pretorius, H. W.、Constant, E. L.、Earley, W. R.、Szamose, J.、Brecher, M.(2009)。Extended- release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results from a randomized, placebo-controlled, double-blind study。J Clin Psychiatry,70,540-549。  new window
26.El-Khalili, N.、Joyce, M.、Atkinson, S.(2010)。Extendedrelease quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multi-centre, randomized, double-blind, placebo-contro。Int J Neuropsychopharmacol,13,917-932。  new window
27.Dunner, D. L.、Laubmeier, K. K.、Manos, G.、Forbes, R. A.、Baker, R. A.、Berman, R. M.(2012)。Benefi cial effects of adjunctive aripiprazole in major depressive disorder are not dependent on antidepressant therapy history: a post hoc analysis of 3 randomized, double-blind, placebocontrolled trials。Prim Care Companion CNS Disorder,14(6)。  new window
28.Rapaport, M. H.、Gharabawi, G. M.、Canuso, C. M.(2006)。Effects of risperidone augmentation in patients with treatment-resistant depression: results of open-label treatment followed by double-blind continuationn。Neuropsychopharmacology,31,2503-2513。  new window
29.Wiles, N.、Thomas, L.、Abel, A.(2013)。Cognitive behavioral therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: result of the CoBaIT randomised controlled trial。Lancet,381,375-384。  new window
30.Trivedi, R. B.、Nieuwsma, J. A.、Williams, J. W. Jr(2011)。Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review。J Gen Intern Med,26,643-650。  new window
31.O'Reardon, J. P.、Solvason, H. B.、Janicak, P. G.(2007)。Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial。Biol Psychiatry,62,1208-1216。  new window
32.Fink, M.(1990)。The practice of ECT: recommendations for treatment, training, and privileging: background。Convul Ther,6,82-84。  new window
33.Rush, A. J.、Marangell, L. B.、Sackeim, H. A.(2005)。Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial。Biol Psychiatry,58,347-354。  new window
34.Carpenter, L. L.、Janicak, P. G.、Aaronson, S. T.(2012)。Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice。Depress Anxiety,29,587-596。  new window
35.Sackeim, H. A.、Brannan, S. K.、Rush, A. J.、George, M. S.、Marangell, L. B.、Allen, J.(2007)。Durability of antidepressant response to vagus nerve stimulation (VNS)。Int J Neuropsychopharmacol,10,817-826。  new window
36.Dunner, D. L.、Fieve, R. R.(1974)。Clinical factors in lithium carbonate prophylaxis failure。Arch. Gen. Psychiatry,30,229-233。  new window
37.Bauer, M. S.、Whybrow, P. C.(1990)。Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high dose levothyroxine: a preliminary study。Arch Gen Psychiatry,47,435-450。  new window
38.Janicak, P. G.、Rado, J. T.(2012)。Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy。Expert Opin Pharmacother,13,1645-1652。  new window
39.Fountoulakis, K. N.、Kasper, S.、Andreassen, O.(2012)。Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry。Eur Arch Psychiatry Clin Neurosci,262(Suppl 1),1-48。  new window
40.Suppes, T.、Webb, A.、Paul, B.、Carmody, T.、Kraemer, H.、Rush, A. J.(1999)。Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania。Am J Psychiatry,156,1164-1169。  new window
41.Remick, R. A.(1958)。Alprazolam-induced manic switch。J Clin Psychiatry,46,406-407。  new window
42.Small, J. G.、Kellams, J. J.、Milstein, V.、Small, I. F.(1980)。Complications with electroconvulsive therapy combined with lithium。Biol Psychiatry,15,103-112。  new window
43.Shelton, R. C.、Tollefson, G. D.、Tohen, M.(200101)。A novel augmentation strategy for treating resistant depression。Am J Psychiatry,158(1),131-134。  new window
44.Hamilton, M.(1967)。Development of a rating scale for primary depressive illness。British Journal of Social & Clinical Psychology,6(4),278-296。  new window
45.Marcus, R. N.、McQuade, R. D.、Carson, W. H.(2008)。The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study。J Clin Psychopharmacol,28,156-165。  new window
46.Montgomery, S. A.、Asberg, M.(1979)。A New Depression Scale Designed to Be Sensitive to Change。The British Journal of Psychiatry,134(4),382-389。  new window
47.Kroenke, Kurt、Spitzer, Robert L.、Williams, Janet B. W.(2001)。The PHQ-9: Validity of a brief depression severity measure。Journal of General Internal Medicine,16(9),606-613。  new window
48.Hamilton, M.(1959)。The assessment of anxiety states by rating。British Journal of Medical Psychology,32(1),50-55。  new window
49.Gergel, Ivan P.、Pitts, Cornelius D.、Oakes, Rosemary、Evans, Dwight L.、Nemeroff, Charles B.、Bowden, Charles L.、Sachs, Gary S.、Gyulai, Laszlo(2001)。Double-blind, Placebo-controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar Depression。The American Journal of Psychiatry,158(6),906-912。  new window
50.Nelson, J. C.、Papakostas, G. I.(2009)。Atypical antipsychotic augmentation in major depressive disorder: a meta- analysiS of placebo-controlled randomized trials。Am J Psychiatry,166,980-991。  new window
研究報告
1.Gaynes, B. N.、Lux, L. J.、Lloyd, S. W.(2011)。Nonpharmacologic interventions for treatment-resistant depression in adults [Internet]。Rockville, MD。  new window
圖書
1.Stahl, S. M.(1996)。Essential Psychopharmacology: Neuroscientific Basis and Clinical Applications。New York:Cambridge University Press。  new window
圖書論文
1.Dunner, D. L.(1984)。Affective Disorders。Current Emergency Therapy 84。Norwalk, Connecticut:Appleton-Century-Crofts。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE